Ypsomed Holding AG/Fr. YPSN
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Ypsomed Holding AG
Ypsomed Holding AG is a Swiss company specializing in the development and manufacturing of injection and infusion systems for self-medication, primarily serving the pharmaceuticals and biotechnology industries. Its key products include insulin pens, autoinjectors, infusion sets, and digital health solutions, catering to therapy areas such as diabetes management. Founded in 1984, the company is headquartered in Burgdorf, Switzerland, and operates globally with subsidiaries and distributors across Europe, North America, and Asia-Pacific regions. Ypsomed leverages its expertise in precision injection technology and its strategic partnerships with leading drug manufacturers to maintain its competitive position in the medical technology sector.
Ticker
Fr. YPSN
Sector
Primary listing
XSWX
Employees
2,025
Headquarters
Burgdorf, Switzerland
Website
YPSN Metrics
BasicAdvanced
CHF 4.6bn
21.61
CHF 16.30
0.74
CHF 2.20
0.31%
Price and volume
Market cap
CHF 4.6bn
Beta
0.74
52-week high
CHF 441.50
52-week low
CHF 260.50
Average daily volume
21k
Dividend rate
CHF 2.20
Financial strength
Current ratio
1.069
Quick ratio
0.735
Long term debt to equity
14.94
Total debt to equity
34.856
Dividend payout ratio (TTM)
13.53%
Interest coverage (TTM)
83.19%
Profitability
EBITDA (TTM)
325.791
Gross margin (TTM)
43.04%
Net profit margin (TTM)
30.36%
Operating margin (TTM)
36.20%
Effective tax rate (TTM)
7.90%
Revenue per employee (TTM)
CHF 360,000
Management effectiveness
Return on assets (TTM)
12.36%
Return on equity (TTM)
31.09%
Valuation
Price to earnings (TTM)
21.607
Price to revenue (TTM)
6.556
Price to book
6.21
Price to tangible book (TTM)
6.33
Price to free cash flow (TTM)
-293.234
Free cash flow yield (TTM)
-0.34%
Free cash flow per share (TTM)
-1.201
Dividend yield (TTM)
0.62%
Forward dividend yield
0.31%
Growth
Revenue change (TTM)
-2.39%
Earnings per share change (TTM)
154.29%
3-year revenue growth (CAGR)
13.69%
10-year revenue growth (CAGR)
8.05%
3-year earnings per share growth (CAGR)
62.20%
10-year earnings per share growth (CAGR)
19.11%
3-year dividend per share growth (CAGR)
50.14%
10-year dividend per share growth (CAGR)
15.97%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs